文献速递瓣膜病与结构性心脏病心力衰竭与心肌病

经导管主动脉瓣置换术前后医院资源利用:STS/ACC TVT注册研究

Hospital Resource Utilization Before and After Transcatheter Aortic Valve Replacement: The STS/ACC TVT Registry.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

基于STS/ACC TVT注册与Medicare理赔链接的15,324例TAVR患者,比较术前与术后1年全因、心血管及非心血管住院率、住院天数与费用。术后心衰住院率与住院天数降低,但全因、非心血管及出血住院增加;术后总费用降低,左室射血分数<30%者住院减少最明显。

要点

  • TAVR术后心衰住院率与住院天数较术前降低。
  • TAVR术后全因、非心血管及出血住院率与天数增加。
  • TAVR术后平均费用降低,LVEF<30%者住院减少最明显。

核心结论

  • TAVR术后患者费用降低、心衰住院减少,但全因、非心血管及出血住院增加。
  • 住院减少因患者亚组而异,需针对术后资源利用增加者优化诊疗流程。

研究设计与样本

  • 基于STS/ACC TVT注册与Medicare理赔链接,纳入15,324例在328个中心接受TAVR的患者。
  • 比较TAVR术前1年与术后1年的全因、心血管及非心血管住院率、住院天数及住院费用。
  • 采用多变量模型确定术后与术前住院及费用的率比。

主要发现

  • 术后心衰住院率率比0.87、住院天数率比0.95,均p<0.01。
  • 术后全因、非心血管及出血住院率与住院天数均增加,p<0.01。
  • 左室射血分数<30%者术后住院减少最明显。
  • 全部TAVR患者术后平均费用率比0.95(p<0.01),1年生存者率比0.90(p<0.01)。

关键数值与推荐

  • 中位年龄84岁,中位STS预测死亡风险评分7.0,61.1%经股动脉入路。

临床怎么用

  • TAVR术后应关注非心血管及出血住院增加,针对高资源利用患者优化术后管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with severe aortic stenosis (AS) have repeat hospitalizations for multiple conditions. OBJECTIVES: The purpose of this study was to assess the effect of transcatheter aortic valve replacement (TAVR) on hospitalizations in severe AS. METHODS: Using data from the Society of Thoracic Surgeons/American College of Cardiology TVT (Transcatheter Valve Therapy) registry with linkage to Medicare claims, the authors examined rates of all-cause, cardiovascular, and noncardiovascular hospitalizations and hospital days, as well as inpatient costs in the year pre-TAVR and post-TAVR. Multivariable modeling was used to determine rate ratios of post-TAVR versus pre-TAVR hospitalizations and costs. RESULTS: Among 15,324 patients at 328 sites with Medicare linkage undergoing TAVR, the median age was 84 years, the median Society of Thoracic Surgeons Predicted Risk of Mortality score was 7.0, and 61.1% patients underwent TAVR via transfemoral access. Post-TAVR, heart failure hospitalization rates and hospitalized days were reduced compared with pre-TAVR (rate ratio: 0.87 and 0.95 respectively; p < 0.01 for all). However, all-cause, noncardiovascular, and bleeding hospitalization rates and hospitalized days were increased (p < 0.01 for all). Post-TAVR hospitalizations were reduced the most among those with left ventricular ejection fraction <30%. Mean post-TAVR costs were reduced among all TAVR patients and among 1-year survivors (rate ratio: 0.95, p < 0.01; and 0.90; p < 0.01, respectively). CONCLUSIONS: Patients had lower costs and fewer heart failure hospitalizations but more all-cause, noncardiovascular, and bleeding hospitalizations post-TAVR. Reduction in hospitalizations varied by specific patient subgroups, and thus, payors and providers seeking to reduce resource use may consider strategies designed to improve processes of care among patients with increased resource utilization post-TAVR as compared with pre-TAVR.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Vemulapalli S, Dai D, Hammill BG, et al. Hospital Resource Utilization Before and After Transcatheter Aortic Valve Replacement: The STS/ACC TVT Registry. J Am Coll Cardiol. 2019. PMID: 30871697. doi:10.1016/j.jacc.2018.12.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。